Before the euro crisis triggered a wave of austerity measures, pharmaceutical companies faced relatively low resistance from European governments regarding prices and new product placement. Cuts in healthcare spending across Europe have been putting pressure on pharmaceutical prices in recent years, a trend that is welcomed by therapists and consumers. One business that supports this development is EUROFARM SRL from Pistoia, Italy. The pharmaceutical distribution company purchases favourably priced drugs in Italy and supplies them to clients abroad, making the financial advantages available to its partners.